US Tariffs on Pharmaceuticals: Limited Impact on Indian Drug Makers
The imposition of a 100% tariff by the US on imports of branded and patented pharmaceutical products is expected to have a limited impact on Indian drug makers, with Sun Pharma being the most exposed to headline risk.